{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:13:58Z","timestamp":1752549238812},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,3,31]],"date-time":"2007-03-31T00:00:00Z","timestamp":1175299200000},"content-version":"vor","delay-in-days":4138,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1995,12]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p> <jats:italic>Background<\/jats:italic>: The severity of gastro\u2010oesophageal reflux disease is generally considered to be related to the extent of oesophageal acid exposure. Current therapies include antisecretory and prokinetic agents. We compared two of these, ranitidine and cisapride, in their ability to lower oesophageal acid exposure in patients with erosive oesophagitis.<\/jats:p><jats:p> <jats:italic>Methods<\/jats:italic>: Seven patients with Savary\u2013Miller's grade II\u2013IV oesophagitis and with oesophageal contact time \u00b1 8% were studied. Mean lower oesophageal sphincter pressure was 4.6 mmHg. Oesophageal acid contact time was 25.6 \u00b1 5.6%. Each patient received ranitidine 150 mg b.d., ranitidine 150 mg q.d.s., or cisapride 10 mg q.d.s. in a randomized 3\u2010way cross\u2010over design. Intra\u2010oesophageal pH was monitored during 24 h for each of these treatments in a controlled hospital environment, while consuming a high fat, high calorie diet.<\/jats:p><jats:p> <jats:italic>Results<\/jats:italic>: Cisapride and ranitidine at both doses decreased the acid contact time and the number of reflux episodes. However, a minority of patients treated with ranitidine, and none with cisapride, diminished their oesophageal acid contact time to a normal value of &lt; 5%. No treatment significantly decreased nocturnal acid exposure.<\/jats:p><jats:p> <jats:italic>Conclusion<\/jats:italic>: In patients with severe gastro\u2010oesophageal reflux disease both cisapride and ranitidine demonstrably lower oesophageal acid exposure, but neither therapy predictably normalizes it.<\/jats:p>","DOI":"10.1111\/j.1365-2036.1995.tb00436.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T11:26:54Z","timestamp":1279884414000},"page":"661-666","source":"Crossref","is-referenced-by-count":10,"title":["A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis"],"prefix":"10.1111","volume":"9","author":[{"given":"P.","family":"POUDEROUX","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"KAHRILAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,31]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"378","volume-title":"Gastrointestinal Pathophysiology, Diagnosis, Management","author":"Kahrilas P J","year":"1993"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.3.246"},{"key":"e_1_2_1_4_2","first-page":"113","article-title":"Cisapride: influence on esophageal and gastric emptying gastroesophageal reflux in patients with reflux esophagities","volume":"34","author":"Collins B J","year":"1987","journal-title":"Hepato-Gastroenterol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(87)91020-1"},{"key":"e_1_2_1_6_2","first-page":"12","volume-title":"The Medical Management Of Oesophageal Reflux Disease","author":"Galmiche J P","year":"1990"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198812000-00007"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200231"},{"key":"e_1_2_1_9_2","first-page":"143","article-title":"Cisapride in esophagitis. A placebo\u2010controlled trial","volume":"34","author":"Huettemann W","year":"1986","journal-title":"Digestion"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00088.x"},{"key":"e_1_2_1_11_2","first-page":"125","article-title":"Cisapride vs. ranitidine in the treatment of reflux esophagitis","volume":"35","author":"Janisch H D","year":"1988","journal-title":"Hepato-gastroenterol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00145.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00114.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01540415"},{"key":"e_1_2_1_15_2","first-page":"403","article-title":"Cisapride and cimetidine in the treatment of erosive esophagitis","volume":"37","author":"Maleev A","year":"1990","journal-title":"Hepato-Gastroenterol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(69)80121-6"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110246"},{"key":"e_1_2_1_18_2","first-page":"G718","article-title":"Mechanisms of H+ injury in rabbit esophageal epithelium","volume":"246","author":"Orlando R C","year":"1984","journal-title":"Am J Physiol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.9.1187"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90162-X"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91790-B"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.7.886"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1991.tb00530.x"},{"key":"e_1_2_1_24_2","first-page":"208","article-title":"Investigation of ranitidine 150 mg b.d. or 300 mg b.d. in the treatment of reflux disease","volume":"33","author":"Schaub N","year":"1986","journal-title":"Hepato-gastroenterol"},{"key":"e_1_2_1_25_2","first-page":"28","article-title":"Esophagitis healing with ranitidine","volume":"22","author":"Pace F","year":"1990","journal-title":"Ital J Gastroenterol"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.1995.tb00436.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.1995.tb00436.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T19:19:39Z","timestamp":1698261579000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.1995.tb00436.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["10.1111\/j.1365-2036.1995.tb00436.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.1995.tb00436.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}